Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
243 studies found for:    "Thalassemia"
Show Display Options
Rank Status Study
1 Completed
Has Results
Assessment of Pain in People With Thalassemia
Condition: Thalassemia
Intervention:
2 Completed
Has Results
Zinc & Bone Health in Thalassemia: The Think Zinc Study
Condition: Thalassemia
Interventions: Dietary Supplement: Zinc;   Dietary Supplement: Placebo
3 Completed
Has Results
Evaluating the Safety and Effectiveness of Decitabine in People With Thalassemia Intermedia
Condition: Thalassemia
Intervention: Drug: Decitabine (USAN, INN)
4 Completed Study of Effects of YisuiShengxueGranules on Thalassemia
Condition: Thalassemia
Intervention: Drug: Yisuishengxue Granule
5 Completed The Change of Coagulation Markers in Children With β-thalassemia Disease After Stem Cell Transplantation
Condition: Thalassemia
Intervention:
6 Completed Study of Efficacy and Safety of INC424 in Regularly Transfused Patients With Thalassemia.
Condition: Thalassemia Major
Intervention: Drug: INC424 (ruxolitinib)
7 Completed Effect of Antioxidant Cocktail in Beta-thalassemia/Hb E Patients
Condition: Thalassemia
Interventions: Drug: curcuminoids, N-acetylcysteine, deferiprone and vitamin E;   Drug: Curcuminoids and alpha-tocopherol
8 Completed
Has Results
Assessment of Pain in People With Thalassemia Who Are Treated With Regular Blood Transfusions
Condition: Thalassemia
Intervention:
9 Completed Evaluation of Efficacy of Zoledronic Acid in Patients With Haemoglobin Syndromes (Thalassemia and Sicle Cell Anaemia) and Risk of Skeletal Events
Condition: Thalassemia
Intervention: Drug: Zoledronic Acid
10 Completed Zinc and Diabetes in Patients With Thalassemia: a Pilot Study
Condition: Thalassemia
Intervention: Dietary Supplement: Zinc Supplementation
11 Completed Endocrine and Nutritional Assessment in B Thalassemia Major
Condition: Thalassemia
Intervention: Other: Nutritional recommendations
12 Completed Perceptions of Thalassemia Major in Singapore: An Exploratory Study of Stigma
Condition: Thalassemia Major
Intervention:
13 Active, not recruiting Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia.
Conditions: Beta Thalassemia Major;   Beta Thalassemia Intermedia
Interventions: Drug: Sotatercept 0.1mg/kg;   Drug: Sotatercept 0.3mg/kg;   Drug: Sotatercept 0.5mg/kg;   Drug: Sotatercept 0.75mg/kg;   Drug: Sotatercept 1.0mg/kg;   Drug: Sotatercept 1.5mg/kg
14 Terminated Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLO
Condition: Thalassemia
Interventions: Drug: Busulfan;   Drug: Fludarabine;   Drug: Campath 1H;   Drug: Cyclophosphamide;   Drug: MESNA
15 Recruiting Gene Therapy for Transfusion Dependent Beta-thalassemia
Condition: Beta-Thalassemia
Intervention: Genetic: Autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene
16 Completed Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia
Condition: Beta-Thalassemia
Interventions: Drug: Deferitrin (GT56-252);   Drug: desferoxamine (DFO)
17 Completed Evaluating the Safety of G-CSF Mobilization in Individuals With Beta Thalassemia Major
Condition: Beta-Thalassemia
Intervention: Drug: Hydroxyurea
18 Completed Evaluating the Safety and Effectiveness of Mozobil Mobilization in Adults With Beta-Thalassemia Major
Condition: Beta-Thalassemia
Intervention: Drug: Mozobil
19 Unknown  Reduced Intensity Transplant Conditioning Regimen for Severe Thalassemia
Condition: Severe Thalassemia
Intervention: Drug: Transplant conditioning regimen of alemtuzumab, fludarabine, and melphalan
20 Active, not recruiting Efficacy and Safety Study of Deferasirox in Patients With Non-transfusion Dependent Thalassemia
Condition: Non-transfusion Dependent Thalassemia
Intervention: Drug: ICL670 deferasirox

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.